A Study on Expected Performance of Certificate System of Green Logistics Company - Comparative Analysis on Green Logistics Performance in Characteristics of Logistics Company -

2013 ◽  
Vol 28 (2) ◽  
pp. 113-133 ◽  
Author(s):  
김영민
2016 ◽  
Vol 78 (8) ◽  
Author(s):  
Roswan Ismail ◽  
Che Zalina Zulkifli ◽  
Khairulanuar Samsudin

Routing in MANET is a challenging task due to the dynamic nature of the participating nodes in MANET. This challenge has led to the development of many different routing protocols, with each originator claiming that his or her proposed protocol was more effective than its predecessors were. Nonetheless, the effectiveness of these protocols relies on the prevailing network scenarios, which differ in terms of node density and traffic. Against this challenging backdrop, the authors provide an overview of the different MANET protocols, such as OLSR, AODV, DSR, DSDV, ZRP and TORA, which are broadly classified based on three categories, namely Proactive (table-driven), Reactive (on-demand) and Hybrid routing protocol. The authors then provide a comparative analysis of the different protocols based on qualitative metrics. This paper concludes by highlighting the expected performance of each protocol for a particular network environment, which is deemed suitable based on the specific characteristics of the protocol.


2020 ◽  
Vol 48 (5) ◽  
pp. 2295-2305
Author(s):  
Jiawei Zhang ◽  
Dandan Li ◽  
Rui Zhang ◽  
Peng Gao ◽  
Rongxue Peng ◽  
...  

The role of miR-21 in the pathogenesis of various liver diseases, together with the possibility of detecting microRNA in the circulation, makes miR-21 a potential biomarker for noninvasive detection. In this review, we summarize the potential utility of extracellular miR-21 in the clinical management of hepatic disease patients and compared it with the current clinical practice. MiR-21 shows screening and prognostic value for liver cancer. In liver cirrhosis, miR-21 may serve as a biomarker for the differentiating diagnosis and prognosis. MiR-21 is also a potential biomarker for the severity of hepatitis. We elucidate the disease condition under which miR-21 testing can reach the expected performance. Though miR-21 is a key regulator of liver diseases, microRNAs coordinate with each other in the complex regulatory network. As a result, the performance of miR-21 is better when combined with other microRNAs or classical biomarkers under certain clinical circumstances.


2007 ◽  
Vol 177 (4S) ◽  
pp. 398-398
Author(s):  
Luis H. Braga ◽  
Joao L. Pippi Salle ◽  
Sumit Dave ◽  
Sean Skeldon ◽  
Armando J. Lorenzo ◽  
...  
Keyword(s):  

2005 ◽  
Vol 173 (4S) ◽  
pp. 178-178
Author(s):  
Stephen O. Ikuerowo ◽  
Stefan A. Machtens ◽  
Markus A. Kuczyk ◽  
Udo Jonas ◽  
Juergen Serth

Sign in / Sign up

Export Citation Format

Share Document